Antiparkinson Agents (administration & dosage) < Antiparkinson Agents (adverse effects) < Antiparkinson Agents (antagonists & inhibitors)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 104.
[20-40] [0 - 20][0 - 50][40-60]

Ident.	Authors (with country if any)	Title
000404 (2004)	Raúl De La Fuente-Fernández [Canada] ; Michael Schulzer ; Edwin Mak ; Donald B. Calne ; A Jon Stoessl	Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.
000405 (2004)	Harold D. Foster [Canada] ; Abram Hoffer	The two faces of L-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis.
000419 (2004)		A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease.
000421 (2004)	Anthony E. Lang [Canada] ; Jose A. Obeso	Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough.
000449 (2004)	Raúl De La Fuente-Fernández [Canada] ; Vesna Sossi ; Zhigao Huang ; Sarah Furtado ; Jian-Qiang Lu ; Donald B. Calne ; Thomas J. Ruth ; A Jon Stoessl	Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias.
000456 (2004)	Ronald B. Postuma [Canada] ; Anthony E. Lang	Homocysteine and levodopa: should Parkinson disease patients receive preventative therapy?
000459 (2004)	Yoshiaki Furukawa [Canada] ; James J. Filiano ; Stephen J. Kish	Amantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations.
000469 (2004)	Michel Panisset [Canada]	Freezing of gait in Parkinson's disease.
000490 (2005)	Tom H. Johnston [Canada] ; Joohyung Lee ; Jordi Gomez-Ramirez ; Susan H. Fox ; Jonathan M. Brotchie	A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease.
000552 (2005)	Jonathan M. Brotchie [Canada]	Nondopaminergic mechanisms in levodopa-induced dyskinesia.
000617 (2006)	Francesca Morgante [Canada] ; Alberto J. Espay ; Carolyn Gunraj ; Anthony E. Lang ; Robert Chen	Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
000618 (2006)	Vesna Sossi [Canada] ; Raúl De La Fuente-Fernández ; Michael Schulzer ; John Adams ; Jon Stoessl	Age-related differences in levodopa dynamics in Parkinson's: implications for motor complications.
000634 (2006)	Cindy Zadikoff [Canada] ; Paula Rochon ; Anthony Lang	Cardiac valvulopathy associated with pergolide use.
000640 (2006)	Mehrdad Ghassemi [Canada] ; Sarah Lemieux ; Mandar Jog ; Roderick Edwards ; Christian Duval	Bradykinesia in patients with Parkinson's disease having levodopa-induced dyskinesias.
000670 (2006)	Pershia Samadi [Canada] ; Paul J. Bédard ; Claude Rouillard	Opioids and motor complications in Parkinson's disease.
000678 (2007)	Sarah Lemieux [Canada] ; Mehrdad Ghassemi ; Mandar Jog ; Roderick Edwards ; Christian Duval	The influence of levodopa-induced dyskinesias on manual tracking in patients with Parkinson's disease.
000794 (2007)	Joseph S. Tauskela [Canada]	MitoQ--a mitochondria-targeted antioxidant.
000800 (2007)	Vicki Oldfield [États-Unis] ; Gillian M. Keating ; Caroline M. Perry	Rasagiline: a review of its use in the management of Parkinson's disease.
000801 (2007)	Jackie Gour [Canada] ; Roderick Edwards ; Sarah Lemieux ; Mehrdad Ghassemi ; Mandar Jog ; Christian Duval	Movement patterns of peak-dose levodopa-induced dyskinesias in patients with Parkinson's disease.
000811 (2008)	Susan M. Calne [Canada] ; Ajit Kumar	Young onset Parkinson's disease. Practical management of medical issues.
000826 (2008)	Stephen J. Kish [Canada] ; Junchao Tong ; Oleh Hornykiewicz ; Ali Rajput ; Li-Jan Chang ; Mark Guttman ; Yoshiaki Furukawa	Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Antiparkinson Agents (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Antiparkinson Agents (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiparkinson Agents (adverse effects)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022